Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to the mechanism by which nucleic acids (such as mRNA, siRNA, or DNA) are delivered into the cytoplasm of cells using lipid nanoparticles (LNPs) that contain pH-responsive ionizable lipids. The key challenge in this process is overcoming endosomal entrapment: after cellular uptake by endocytosis, LNPs are sequestered within endosomes. Efficient delivery requires these particles to escape from the endosome before degradation occurs in lysosomes. The mechanism involves pH-dependent protonation of ionizable lipids, leading to membrane interactions, phase transitions, and ultimately endosomal disruption and release of the nucleic acid payload.
Protonation of ionizable lipids in the acidic environment of endosomes leads to membrane disruption and release of encapsulated nucleic acids into the cytoplasm.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular nucleic acid delivery via pH-responsive ionizable lipid-mediated endosomal escape.